MAI Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.68M | Buy |
9,511
+490
| +5% | +$182K | 0.01% | 545 |
|
|
2026
Q1 | $2.64M | Sell |
9,021
-35,491
| -80% | -$11.7M | 0.01% | 526 |
|
|
2025
Q4 | $15.6M | Buy |
44,512
+10,992
| +33% | +$3.71M | 0.09% | 192 |
|
|
2025
Q3 | $10.8M | Buy |
33,520
+25,941
| +342% | +$8.07M | 0.07% | 241 |
|
|
2025
Q2 | $2.95M | Sell |
7,579
-109
| -1% | -$43.8K | 0.02% | 422 |
|
|
2025
Q1 | $3.34M | Sell |
7,688
-5,218
| -40% | -$2.09M | 0.03% | 384 |
|
|
2024
Q4 | $4.76M | Sell |
12,906
-1,509
| -10% | -$631K | 0.04% | 327 |
|
|
2024
Q3 | $7.5M | Sell |
14,415
-809
| -5% | -$432K | 0.07% | 208 |
|
|
2024
Q2 | $8.25M | Buy |
15,224
+1,333
| +10% | +$705K | 0.08% | 194 |
|
|
2024
Q1 | $7.2M | Buy |
13,891
+5,506
| +66% | +$2.74M | 0.07% | 210 |
|
|
2023
Q4 | $3.95M | Buy |
8,385
+3,563
| +74% | +$1.65M | 0.05% | 227 |
|
|
2023
Q3 | $2.1M | Sell |
4,822
-235
| -5% | -$107K | 0.03% | 293 |
|
|
2023
Q2 | $2.25M | Sell |
5,057
-30
| -0.6% | -$13.8K | 0.03% | 282 |
|
|
2023
Q1 | $2.34M | Sell |
5,087
-966
| -16% | -$460K | 0.04% | 262 |
|
|
2022
Q4 | $3.11M | Buy |
6,053
+653
| +12% | +$332K | 0.05% | 222 |
|
|
2022
Q3 | $2.45M | Buy |
5,400
+1,467
| +37% | +$702K | 0.05% | 231 |
|
|
2022
Q2 | $1.9M | Sell |
3,933
-51
| -1% | -$25.2K | 0.04% | 265 |
|
|
2022
Q1 | $1.96M | Buy |
3,984
+64
| +2% | +$29.3K | 0.03% | 271 |
|
|
2021
Q4 | $1.82M | Sell |
3,920
-92
| -2% | -$38.7K | 0.03% | 298 |
|
|
2021
Q3 | $1.5M | Buy |
4,012
+632
| +19% | +$240K | 0.03% | 295 |
|
|
2021
Q2 | $1.29M | Buy |
3,380
+119
| +4% | +$45.5K | 0.03% | 310 |
|
|
2021
Q1 | $1.17M | Buy |
3,261
+1,028
| +46% | +$331K | 0.03% | 311 |
|
|
2020
Q4 | $717K | Buy |
2,233
+313
| +16% | +$96.1K | 0.02% | 389 |
|
|
2020
Q3 | $516K | Buy |
1,920
+7
| +0.4% | +$1.88K | 0.01% | 395 |
|
|
2020
Q2 | $503K | Sell |
1,913
-39
| -2% | -$10.4K | 0.02% | 393 |
|
|
2020
Q1 | $443K | Sell |
1,952
-21
| -1% | -$5.72K | 0.02% | 380 |
|
|
2019
Q4 | $596K | Buy |
1,973
+161
| +9% | +$44.3K | 0.02% | 373 |
|
|
2019
Q3 | $435K | Sell |
1,812
-80
| -4% | -$21.9K | 0.02% | 372 |
|
|
2019
Q2 | $534K | Buy |
1,892
+645
| +52% | +$176K | 0.02% | 341 |
|
|
2019
Q1 | $358K | Sell |
1,247
-8
| -0.6% | -$2.31K | 0.02% | 334 |
|
|
2018
Q4 | $330K | Hold |
1,255
| – | – | 0.02% | 336 |
|
|
2018
Q3 | $344K | Sell |
1,255
-22
| -2% | -$5.71K | 0.02% | 337 |
|
|
2018
Q2 | $304K | Buy |
1,277
+11
| +0.9% | +$2.55K | 0.02% | 360 |
|
|
2018
Q1 | $278K | Buy |
1,266
+36
| +3% | +$8.46K | 0.02% | 365 |
|
|
2017
Q4 | $277K | Hold |
1,230
| – | – | 0.02% | 371 |
|
|
2017
Q3 | $234K | Hold |
1,230
| – | – | 0.01% | 386 |
|
|
2017
Q2 | $231K | Buy |
+1,230
| New | +$221K | 0.01% | 392 |
|
|
2015
Q4 | – | Sell |
-2,075
| Closed | -$291K | – | 415 |
|
|
2015
Q3 | $291K | Hold |
2,075
| – | – | 0.02% | 345 |
|
|
2015
Q2 | $341K | Sell |
2,075
-280
| -12% | -$44.7K | 0.02% | 348 |
|
|
2015
Q1 | $364K | Sell |
2,355
-400
| -15% | -$57K | 0.02% | 343 |
|
|
2014
Q4 | $346K | Hold |
2,755
| – | – | 0.02% | 329 |
|
|
2014
Q3 | $330K | Hold |
2,755
| – | – | 0.03% | 285 |
|
|
2014
Q2 | $296K | Hold |
2,755
| – | – | 0.03% | 302 |
|
|
2014
Q1 | $274K | Buy |
2,755
+195
| +8% | +$17.6K | 0.03% | 317 |
|
|
2013
Q4 | $237K | Hold |
2,560
| – | – | 0.03% | 321 |
|
|
2013
Q3 | $214K | Hold |
2,560
| – | – | 0.03% | 305 |
|
|
2013
Q2 | $210K | Buy |
+2,560
| New | +$192K | 0.03% | 284 |
|
Other funds holding ELV
MAI Capital Management's ELV Position: Q2 2026 in Review
MAI Capital Management increased its Elevance Health (ELV) stake by 5.4% in Q2 2026, buying an estimated $182K and bringing the position to 9,511 shares worth $3.68M. The position accounts for 0.01% of the portfolio, ranked #545.
MAI Capital Management first reported a position in ELV in Q2 2013 and has held it in 47 quarters since. The position peaked at $15.6M in Q4 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- MAI Capital Management held 9,511 shares of Elevance Health worth $3.68M as of Q2 2026.
- MAI Capital Management bought 490 Elevance Health shares in Q2 2026, an estimated $182K.
- Elevance Health made up 0.01% of MAI Capital Management's portfolio in Q2 2026, its #545 holding.
- MAI Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 47 quarters since.
- MAI Capital Management's Elevance Health position peaked at $15.6M in Q4 2025.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.